Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Skin Neoplasms × Sirolimus × Clear all

Phase

Phase 4 3 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Tuberous Sclerosis 2 Myelodysplastic Syndromes 2 Lymphangioleiomyomatosis 2 Leukemia, Myeloid, Acute 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hodgkin Disease 2 Graft vs Host Disease 2 Carcinoma, Hepatocellular 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 PRETEXT I Hepatoblastoma 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Epilepsy 1 Drug Resistant Epilepsy 1 Breast Neoplasms 1 Birt-Hogg-Dube Syndrome 1

Interventions

Dacarbazine 4 cemiplimab 2 binimetinib 2 Ipilimumab 2 vitespin 1 trametinib 1 tilsotolimod 1 spartalizumab 1 pembrolizumab 1 oblimersen 1 gp100 Melanoma Antigen 1 encorafenib 1 dabrafenib 1 bempegaldesleukin 1 aldesleukin 1 Vinblastine 1 Vemurafenib 1 Tretinoin 1 Standard of Care 1 Sodium Chloride 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Interleukin-2 1 Interferon-alpha 1 Interferon alpha-2 1 Injections 1 Everolimus 1 Educational Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05860881 2025-09-09

SiroSkin

Melanoma and Skin Cancer Trials Limited

Phase 3 Active not recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡